Jiangsu Hengrui Medicine Co., Ltd. Jiangsu Hengrui Medicine Co., Ltd.

Jiangsu Hengrui Medicine Co., Ltd.

600276

株式のランク #544
Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged... Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged in the full spectrum of pharmaceutical operations, from the initial discovery and development of medications to their manufacturing and worldwide distribution. The company is actively advancing a substantial pipeline of drug candidates, which includes Apatinib, Pyrotinib, Mecapegfilgrastim, SHR3680, SHR3162, SHR9549, SHR2554, SHR1459, SHR-1309, SHR-A1201, Camrelizumab, Famitinib, SHR-1316, SHR-1501, SHR-1603, SHR-1701, SHR-1702, and SHR-A1403. These prospective treatments are aimed at a diverse range of medical conditions, primarily focusing on oncology, metabolic disorders, pain management, and autoimmune diseases, among others. The enterprise was founded in 1970 and maintains its corporate headquarters in Lianyungang, China.
株価
$6.89
時価総額
$43.94B
変化(1日)
-2.91%
変化(1年)
-24.78%
国
CN
取引 Jiangsu Hengrui Medicine Co., Ltd. (600276)

カテゴリー

Healthcare
Jiangsu Hengrui Medicine Co., Ltd.(600276)の発行済株式数
October 2026 時点の発行済株式数 0
Jiangsu Hengrui Medicine Co., Ltd. の最新の財務報告および株価によると、現在の発行済株式数は 0 です。October 2026 の終わりには、同社は 0 株の発行済株式 を有していました。発行済株式数は、通常、株式分割や自社株買いによって影響を受けます。
Jiangsu Hengrui Medicine Co., Ltd.(600276)の発行済株式数の履歴(2001 ~ 2026)
各年末時点の発行済株式数
年 発行済株式数 変化
2025 6.50B 2.58%
2024 6.34B 0.15%
2023 6.33B -0.63%
2022 6.37B -0.21%
2021 6.38B 0.38%
2020 6.36B 0.31%
2019 6.34B -0.42%
2018 6.36B 1.14%
2017 6.29B -0.45%
2016 6.32B -0.18%
2015 6.33B 0.46%
2014 6.30B -0.11%
2013 6.31B 0.29%
2012 6.29B -0.01%
2011 6.29B 0.36%
2010 6.27B 0.00%
2009 6.27B 0.26%
2008 6.25B -0.01%
2007 6.25B 0.00%
2006 6.25B 87.25%
2005 3.34B 0.00%
2004 3.34B 0.00%
2003 3.34B 0.00%
2002 3.34B 0.00%
2001 3.34B 0.00%
類似企業や競合他社の発行済株式数